Key result
Optimizing DAPT is essential to reduce bleeding and ischemic events after PCI or ACS.
Why the study?
Optimizing the risks and benefits of dual antiplatelet therapy is paramount for preventing bleeding and ischemic events after PCI or acute coronary syndrome.
How can the risks and benefits of dual antiplatelet therapy be optimized after ACS or PCI?
How can the risks and benefits of dual antiplatelet therapy be optimized after ACS or PCI?
Answers are grounded in this paper and cite their sources.
This paper discusses strategies for optimizing the balance between bleeding and ischemic risks when using dual antiplatelet therapy after ACS or PCI.
Optimizing risks and benefits of dual antiplatelet therapy (DAPT) is paramount for the prevention of bleeding and ischemic events after percutaneous coronary intervention (PCI) or acute coronary sy...
No takes yet. Share an insight, caveat, or question.
Landi et al. (2025) studied this question. Dual antiplatelet therapy optimization is paramount for preventing bleeding and ischemic events after percutaneous coronary intervention or acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: